Page last updated: 2024-08-22

megestrol and Angioblastic Meningioma

megestrol has been researched along with Angioblastic Meningioma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Aboukais, R; Bourgeois, P; Caron, S; De Witte, O; Devalckeneer, A; Lejeune, JP; Maurage, CA; Perbet, R; Racape, J1
Bahamondes, L; Facchinetti, F; Grandi, G; Marani, G1
Esposito, G; La Vecchia, C; Parazzini, F; Santucci, C; Vercellini, P1
AbiJaoude, S; Cornu, P; Kalamarides, M; Marijon, P; Peyre, M; Roblot, P; Tran, S1
Champagne, PO; Froelich, S; Passeri, T1
Bernat, AL; Champagne, PO; Froelich, S; Hanakita, S; Mandonnet, E; Passeri, T; Salle, H1
Schulder, M; Sharer, L; Vadivelu, S1
Grunberg, SM; Weiss, MH1

Other Studies

8 other study(ies) available for megestrol and Angioblastic Meningioma

ArticleYear
Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Aged; Chlormadinone Acetate; Cyproterone Acetate; Female; Humans; Magnetic Resonance Imaging; Male; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Norpregnadienes; Retrospective Studies

2021
We donĀ“t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2022, Volume: 27, Issue:5

    Topics: Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Humans; Male; Megestrol; Meningeal Neoplasms; Meningioma

2022
Nomegestrol acetate for symptomatic endometriosis and meningioma risk: understandable statistics for decision-making.
    European journal of obstetrics, gynecology, and reproductive biology, 2023, Volume: 286

    Topics: Endometriosis; Female; Humans; Megestrol; Meningeal Neoplasms; Meningioma; Norpregnadienes

2023
Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy.
    Acta neurochirurgica, 2021, Volume: 163, Issue:6

    Topics: Cell Proliferation; Cyproterone Acetate; Female; Humans; Magnetic Resonance Imaging; Male; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Progestins

2021
Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.
    Acta neurochirurgica, 2019, Volume: 161, Issue:3

    Topics: Cyproterone Acetate; Female; Humans; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Norpregnadienes

2019
Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients.
    Acta neurochirurgica, 2019, Volume: 161, Issue:4

    Topics: Adult; Aged; Female; Humans; Magnetic Resonance Imaging; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged; Norpregnadienes; Retrospective Studies; Withholding Treatment

2019
Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.
    Journal of neurosurgery, 2010, Volume: 112, Issue:5

    Topics: Brain Neoplasms; Contraceptives, Oral, Synthetic; Female; Humans; Magnetic Resonance Imaging; Megestrol; Meningioma; Middle Aged; Neoplasm Invasiveness; Neurosurgical Procedures; Receptors, Progesterone; Time Factors

2010
Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma.
    Journal of neuro-oncology, 1990, Volume: 8, Issue:1

    Topics: Adult; Antineoplastic Agents; Female; Humans; Male; Megestrol; Meningeal Neoplasms; Meningioma; Middle Aged

1990